ARTL — ARTELO BIOSCIENCES INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 8 SEC-registered investment managers reported holding ARTL (ARTELO BIOSCIENCES INC) in their latest 13F filings, with a combined reported value of $122.63K across 30.35K shares. That is -67.8% by share count (-55.89K shares) versus the previous quarter, while reported value moved +16.1%. Ownership is concentrated: the five largest holders account for 99.2% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 4 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ARTELO BIOSCIENCES INC (ARTL) include Kathmere Capital Management, LLC, Renaissance Technologies, UBS Group AG, ranked by reported 13F value among the 35 institutional holders on this page.
ARTL is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 8 | 30.35K | $122.63K | -67.8% |
| Q2 2026 | 11 | 130.98K | $147.50K | +201.8% |
| Q1 2026 | 11 | 46.49K | $829.87K | +48.4% |
| Q4 2025 | 9 | 98.50K | $120.60K | +234.5% |
| Q3 2025 | 7 | 15.86K | $72.78K | +1591.7% |
| Q2 2025 | 8 | 16.59K | $220.12K | -61.9% |
| Q1 2025 | 8 | 86.59K | $75.76K | +26.0% |
| Q4 2024 | 6 | 34.52K | $36.59K | -6.0% |
Over the 8 quarters shown, institutional share counts decreased 12% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q3 2025 (+1591.7%).
Top Institutional Holders (Q3 2026) — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.02K | $52.60K | 0.00% | Add | |
| 12.03K | $48.60K | 0.00% | Reduce | |
| 3.57K | $14.44K | 0.00% | New | |
| 1.13K | $4.55K | 0.00% | Reduce | |
| 350 | $1.41K | 0.00% | Reduce | |
| 142 | $581 | 0.00% | New | |
| 111 | $448 | 0.00% | New | |
| 1 | $4 | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 66.34K | $74.30K | 0.00% | Add | |
| 13.86K | $15.53K | 0.00% | New | |
| 13.86K | $15.53K | 0.00% | New | |
| 12.40K | $14.69K | 0.00% | New | |
| 10.13K | $11.34K | 0.00% | Hold | |
| 8.44K | $9.45K | 0.00% | Add | |
| 3.14K | $3.52K | 0.00% | Hold | |
| 2.80K | $3.14K | 0.00% | New | |
| 2 | $2 | 0.00% | Hold | |
| 2 | $2 | 0.00% | New | |
| 1 | $1 | 0.00% | New |
Q1 2026 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 889 | $484.19K | 0.01% | New | |
| 13.25K | $100.44K | 0.01% | New | |
| 13.08K | $99.14K | 0.00% | New | |
| 10.13K | $76.78K | 0.00% | New | |
| 3.14K | $23.79K | 0.00% | New | |
| 3.08K | $23.32K | 0.00% | New | |
| 2.83K | $21.42K | 0.00% | Add | |
| 100 | $758 | 0.00% | New | |
| 2 | $15 | 0.00% | Hold | |
| 1 | $8 | 0.00% | New | |
| 1 | $7 | 0.00% | Hold |
Q4 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 33.62K | $41.02K | 0.00% | Add | |
| 20.67K | $25.22K | 0.00% | New | |
| 16.86K | $21.00K | 0.00% | New | |
| 14.03K | $17.11K | 0.00% | Hold | |
| 11.40K | $13.90K | 0.00% | New | |
| 1.90K | $2.32K | 0.00% | New | |
| 17 | $21 | 0.00% | Add | |
| 2 | $2 | 0.00% | Hold | |
| 1 | $1 | 0.00% | New |
Q3 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 14.03K | $64.39K | 0.00% | New | |
| 1.10K | $5.05K | 0.00% | Add | |
| 477 | $2.19K | 0.00% | Add | |
| 209 | $959 | 0.00% | Add | |
| 30 | $138 | 0.00% | Add | |
| 11 | $50 | 0.00% | Add | |
| 2 | $9 | 0.00% | New |
Q2 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 16.03K | $212.74K | 0.00% | Reduce | |
| 447 | $5.93K | 0.00% | Reduce | |
| 89 | $1.18K | 0.00% | Reduce | |
| 9 | $119 | 0.00% | New | |
| 5 | $66 | 0.00% | Reduce | |
| 4 | $53 | 0.00% | Reduce | |
| 1 | $13 | 0.00% | New | |
| 1 | $13 | 0.00% | New |
New Positions (Q3 2026)
- Citigroup Inc 3.57K sh · $14.44K
- Robinhood Markets, Inc. 142 sh · $581
- Altshuler Shaham Ltd 111 sh · $448
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 13.86K sh · $15.53K
- Geode Capital Management sold 13.86K sh · $15.53K
- StoneX Group Inc. sold 12.40K sh · $14.69K
- Tower Research Capital LLC (TRC) sold 8.44K sh · $9.45K
- ROTHSCHILD INVESTMENT LLC sold 2 sh · $2
- DANSKE BANK A/S sold 1 sh · $1
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UBS Group AG | 13.02K | 2.80K | — | 33.62K | 209 | 89 | 12.77K | 13.30K | — | — | 125 | — | 112 | — | 2.38K | 3.05K | 3.98K | 48.96K | 18.28K | — |
| JANE STREET GROUP, LLC | 12.03K | 66.34K | 13.08K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 3.57K | — | 3.08K | — | 477 | 9 | — | — | — | 46 | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.13K | 10.13K | 10.13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 350 | 3.14K | 3.14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Robinhood Markets, Inc. | 142 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Altshuler Shaham Ltd | 111 | — | 889 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| TD Waterhouse Canada Inc. | 1 | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | — | 13.86K | — | 11.40K | — | 16.03K | 26.76K | 17.35K | 17.35K | 19.81K | 19.81K | 19.81K | 19.81K | 13.71K | 13.71K | 13.71K | 12.47K | 187.07K | 167.83K | 162.75K |
| Kathmere Capital Management, LLC | — | — | 13.25K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 182.62K | 108.80K |
| Vanguard Group | — | — | — | 14.03K | 14.03K | — | — | — | — | — | — | — | — | — | — | 62.58K | 71.04K | 683.90K | 683.90K | 890.92K |
| HRT FINANCIAL LP | — | — | — | — | — | — | — | — | — | — | — | — | 30.28K | — | — | — | — | — | — | — |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 62.52K | 62.52K | 62.52K |
| Two Sigma Investments | — | — | — | 20.67K | — | — | — | — | — | — | — | — | — | — | — | — | 10.61K | — | — | — |
| Tower Research Capital LLC (TRC) | — | 8.44K | 2.83K | 1.90K | — | 447 | 3.90K | 3.82K | 5.18K | 5.82K | 4.87K | 4.80K | 2.14K | — | — | — | — | — | — | — |
| Virtu Financial LLC | — | — | — | 16.86K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | — | — | — | — | — | — | 22.71K | — | — | — | — | — | — | — | — | — | — | — | — | 78.59K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | — | — | — | — | — | 20.39K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 13.86K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ARTL?
As of 2026-Q3, 8 institutional funds reported holding ARTL (ARTELO BIOSCIENCES INC) in SEC 13F filings, with a combined reported value of $122.63K.
How many shares of ARTL do institutions own?
13F filers reported 30.35K shares of ARTL, worth $122.63K in aggregate at the end of 2026-Q3.
Is institutional ownership of ARTL rising or falling?
Share counts moved -67.8% versus the prior quarter — distribution.
Who are the top institutional holders of ARTL?
The largest 13F holders are Kathmere Capital Management, LLC, Renaissance Technologies, UBS Group AG, JANE STREET GROUP, LLC, HRT FINANCIAL LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ARTELO BIOSCIENCES INC?
The major shareholders of ARTELO BIOSCIENCES INC (ARTL) by reported 13F value are Kathmere Capital Management, LLC, Renaissance Technologies, UBS Group AG, JANE STREET GROUP, LLC, HRT FINANCIAL LP, among 35 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.